This thesis aims to critically analyze and discuss the article “Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stromal Cells as an Efficient Nanocarrier to Deliver siRNA or Drug to Pancreatic Cancer Cells”, which investigates the in vitro feasibility of using extracellular vesicles derived from human umbilical cord mesenchymal stromal cells as a delivery system for pancreatic ductal adenocarcinoma (PDAC). PDAC is one of the most aggressive and common forms of cancer worldwide, with a poor prognosis mainly due to its often late diagnosis. The article under review investigates the possibility of exploiting EVs loaded with two types of therapeutic cargo: siRNA targeting the mutated KRAS-G12 gene and the chemotherapeutic drug doxorubicin (DOXO). Following these treatments, a decrease in cell viability, proliferation, and migration, as well as cell-cycle arrest in the S phase, was observed, suggesting that this therapeutic strategy could represent an innovative approach for the treatment of pancreatic cancer.
Questa tesi compilativa si propone di analizzare e commentare in modo critico l’articolo “Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stromal Cells as an Efficient Nanocarrier to Deliver siRNA or Drug to Pancreatic Cancer Cells”, che valuta la possibilità in vitro, di usare vescicole extracellulari derivate dalle cellule mesenchimali del cordone ombelicale umano, come metodo di delivery nel carcinoma pancreatico (PDAC). Il PDAC è una delle forme di neoplasia più aggressive e comuni al mondo, con una prognosi sfavorevole data principalmente da una diagnosi spesso tardiva. L’articolo preso in esame valuta la possibilità in vitro, di sfruttare le EVs caricandole con due tipi di cargo terapeutico: siRNA per il gene mutato KRAS-G12 e il farmaco chemioterapico doxorubicina (DOXO). Dopo questi trattamenti si è notato una diminuzione di vitalità, proliferazione e migrazione cellulare e l’arresto del ciclo cellulare nella fase S, suggerendo che tale terapia possa essere un approccio terapeutico innovativo per il trattamento del carcinoma pancreatico.
Silenziamento genico del gene KRAS mediante siRNA incapsulati in vescicole extracellulari
BONETTO, GRETA
2025/2026
Abstract
This thesis aims to critically analyze and discuss the article “Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stromal Cells as an Efficient Nanocarrier to Deliver siRNA or Drug to Pancreatic Cancer Cells”, which investigates the in vitro feasibility of using extracellular vesicles derived from human umbilical cord mesenchymal stromal cells as a delivery system for pancreatic ductal adenocarcinoma (PDAC). PDAC is one of the most aggressive and common forms of cancer worldwide, with a poor prognosis mainly due to its often late diagnosis. The article under review investigates the possibility of exploiting EVs loaded with two types of therapeutic cargo: siRNA targeting the mutated KRAS-G12 gene and the chemotherapeutic drug doxorubicin (DOXO). Following these treatments, a decrease in cell viability, proliferation, and migration, as well as cell-cycle arrest in the S phase, was observed, suggesting that this therapeutic strategy could represent an innovative approach for the treatment of pancreatic cancer.| File | Dimensione | Formato | |
|---|---|---|---|
|
Bonetto_Greta.pdf
accesso aperto
Dimensione
1.19 MB
Formato
Adobe PDF
|
1.19 MB | Adobe PDF | Visualizza/Apri |
The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License
https://hdl.handle.net/20.500.12608/114838